• 제목/요약/키워드: Trial

검색결과 7,907건 처리시간 0.031초

육용계에 있어서 계통간 산육능력 및 체중증가에 따른 각 부위별 증가양상 추정에 관한 연구 (Studies on the Estimation of Growth Pattern Cut-up Parts in Four Broiler Strain in Growing Body Weight)

  • 양봉국;조병욱
    • 한국가금학회지
    • /
    • 제17권3호
    • /
    • pp.141-156
    • /
    • 1990
  • 본 연구는 육용계육종개량에 필요한 기초자료를 얻기 위하여 육용계 4계통(H, T, M, A)을 306수 공시하여 성장률 및 체중증가에 따른 체중구성요소들과 산육률의 상대비율(%)을 Trial 1 (생체중:900~l,000g), Trial 2 (생체중 : 1,300~l,500g), Trial 3 (성체중 1,600~1,800g), 그리고 Trial 4 (생체중 :1.8kg 이상) 순서로 추정하였다. 공시된 Broiler는 1987년 7월 2일부터 동년 9월 13일까지 서울대학교 농과대학 가축육종 농장에서 사육되었고, 도체시험을 가하였다. 조사사항 및 방법은 전기한 바와 같다. 본 연구에서 얻어진 결과를 요약하면 다음과 같다. 1. 4계통(H, T, M, A) 각각에서 7주령 체중과 0~7까지의 사료효율 및 생존율을 살펴보면 H계통은 $2.150\pm$34.9, 2.55 및 99.7%였으며, T계통은 $2.138\pm$26.2, 2.125 및 99.7%, M계통은 $1.960\pm$23.1과 2.084 및 100.0%였고 A계통은 $2.319\pm$27.9와 2.030 및 100.0%였다. 4계통 모두 정상발육을 하였다. 2. 0~7주령까지 2주간격으로 조사한 성장률에 대한 성적을 살펴보면 2주령을 제외한 전주령에서 계통간에 뚜렷한 유의차를 보였다. 성장속도를 표시해 주는 회귀계수값 기울기 b값을 보면, bA=1.015, bH=0.968, bM=0.950, bT=0.942순으로, A계통의 경우 bA=1.015로서 유의적으로 제일 빠른 속도로 성장하고 있음을 나타내고 있다. 3. 체중구성요소들 체중증가에 따라 각부위들의 체중비율이 증가되는 부위는 다음과 같다. 우모, 복부지방 및 흉부 그러고 퇴경부 등이고, 반면에 감소되고 있는 부위는 방혈중, 두부, 가식내장 및 불가식내장이었고, 체중증가에도 큰 변화가 없는 것을 익부 및 배부이었다. 각 부위별 계통간 유의차를 보이는 것은 우모의 경우 Trial 4에서 계통간 유의차를 보였고, 각부의 경우는 Trial 3에서 계통간 유의차를 보였으며 복부지방량의 경우 Trial 1에 유의차를 보인 뒤 나머지 단계에서는 유의차를 보이지 않았다. 가식부위들 중 계통간간 유의차가 있는 것은 경부에서(Trial 2) 나타났다. 정육이 가장 많이 퇴경부와 흉부의 중량비율(%)을 살펴보면 Trial 4에서 흉부중양비율(%)은 H, T, M, A계통에서 19.2, 19.0, 19.0, 19.0%였고 퇴경부 경우는 23.0%, 23.3, 22.8 그러고 23.0%로 흉부중량비율(%)보다 퇴경부중양비율(%)이 훨씬 높게 나타났다. 체중증가에 따른 증가속도는 흉부가 머 빠른 속도로증가했다. 4. 흉부와 퇴경부의 산육률을 보면 폐부의 산육률에 있어서 계통간 유의차는 Trial 2와 Trial 4에서 산육률의 계통간 유의차를 보였다. 증가속도가 제일 빠른 T계통은 흉폐부근육위주로 개량되었다고 판단된다. Trial 4에서 각 계통간(H, T, M, A)에서 각부의 산육률을 보면 각각 77.2%, 78.9%, 73.5%, 74.8%를 나타냈으며, 퇴경부의 경우 계통간유의차를 나타내지 않았으나 H계통의 경우는 성장속도가 제일 빠르게 나타났다. 반면, 흉부에서 제일 성장속도가 빨랐던 T계통은 퇴경부 산흉율은 bT=0.775로 오히려 감소속도를 나타내고 있다. 한편 퇴경부 산육율을 H, T, M, A계통별로 살펴보면 80.3%, 78.4%. 79.7% 그리고 80.2%였다. 5. 체중구성요소들의 중상비율간의 상관근도는 계통간를 차이를 보이지 않았다. 체중구성요소중 체중과 상관정도가 높은 부위들은 방혈양, 두부, 각부, 흉부, 퇴경부등이였다. 복부지방(%)은 어느 계종에서나 주로 불가식내장과 높은 유의상관을 보였으나, 가식부위와의 상관정도는 매우 낮게 나타났다.

  • PDF

건강한 한국인 피험자에서 Entecavir 1 mg 제제의 약동학적 특성 평가 (Pharmacokinetic Propertiese of Entecavir 1 mg in Korean Healthy Volunteers)

  • 전지영;황민호;임용진;김윤정;한수미;임성혁;채수완;김민걸
    • 한국임상약학회지
    • /
    • 제21권3호
    • /
    • pp.224-227
    • /
    • 2011
  • Entecavir is a potent and selective guanosine analogue that has demonstrated a significant antiviral efficacy against hepatitis B virus (HBV). The aim of this study was to evaluate the safety and pharmacokinetic profile after a single dose of entecavir 1 mg administration in Korean healthy male subjects. Eight volunteers were enrolled. After a single dose of 1 mg entecavir was orally administered, blood samples were collected at specific time intervals from 0-168 hours. The plasma concentrations of entecavir were determined by LC-MS/MS. The pharmacokinetic parameters were determined from the plasma concentration-time profiles. The mean values for $AUC_{last}$ and $AUC_{inf}$ were $14.84{\pm}7.81ng{\cdot}hr/mL$ and $20.71{\pm}8.80ng{\cdot}hr/mL$, respectively. The mean value for $C_{max}$ was $9.19{\pm}4.91ng/ml$ and median value for $t_{max}$ was 0.58 hr. No adverse events were reported by subjects or found on analysis of vital signs or laboratory tests. The results are suggested to be useful in clinical trials of entecavir in Korean subject including bioequivalence study.

빙두께 및 강도 보정기법을 이용한 모형시험결과의 실선시운전 적용연구 (Study on the Correction Method of Ice Strength and Thickness Applied to the Sea Trial Condition Based on the Ice Model Test Results)

  • 이승기;김문찬;이원준;김현수;이춘주
    • 대한조선학회논문집
    • /
    • 제48권5호
    • /
    • pp.457-464
    • /
    • 2011
  • This paper deal with the validation of correction method of ice strength and thickness to the sea trial condition based on the ice model test results. It is very difficult to conduct the model test corresponding to the sea trial condition exactly. In addition, the available sea trial data is not sufficient for the validation of correction method. In the present study, the model test results of Terry-Fox ice breker have been used to compare the corrected results of sea trial test by varying its thickness and strength of model ice. The HSVA and ITTC methods have been applied to the present comparisions and the required power has been also validated by using the HSVA method. There are rather good agreement between the sea trial result and model test corrected by the HSVA and ITTC method. The more comparisons are expected to be carried out in near future.

근거 중심 의학(EBM)에 바탕을 둔 임상시험(Clinical Trial)에서 침 치료 문제점과 개선 방안에 대하여 (The Problem and Improvement Plan on Acupuncture Treatment in Clinical Trial Based on EBM)

  • 한성수;구창모;홍권의;박양춘;최선미
    • Journal of Acupuncture Research
    • /
    • 제23권6호
    • /
    • pp.1-8
    • /
    • 2006
  • Introduction : Even though Acupuncture has been know for its effect for a long time, recently it is required to verifiy its effect. To solve this, clinical trial, based on EBM, has been the way to explain acupuncture's treatment effect. Methods: Last year we had a clinical trial based on acupuncture. From this experience we came to a conclusion mentioned below. Results : 1. To find out acupuncture's effect more certainly, it is needed that Korean medical method or treatment should be connected to diagnosis. 2. We had found out that sham and minimal acupuncture are the most appropriate way in single blinding. 3. It is required for the acupuncturist to practice the right real acupuncture point and sham's point in clinical trial. 4. The most important thing to maintain the subjects from dropping out is to always be concerned to the subjects and management them. Conclusion : The best way to advance clinical trial on acupuncture is to use single blinding system with sham acupuncture together in controlled groups and most of all also needs a standardized acupuncture point and depth.

  • PDF

효율성 측정지표를 활용한 전자적 임상시험프로세스 효과분석 (Effect Analysis of Electronic Clinical Trial Systems)

  • 이현주;최인영
    • 한국콘텐츠학회논문지
    • /
    • 제11권1호
    • /
    • pp.350-356
    • /
    • 2011
  • 본 연구의 목적은 전자적 임상시험 데이터 관리를 위한 설계 시 시간적 요인에 주목하여 시스템의 효율성을 검증해 보고자 함이다. 임상시험 데이터 관리에 대한 관심이 커지고 있고 시스템 도입이 활발한 데 반해, 실제 효율성 측정에 관한 실증연구는 많지 않다. 특히 국내의 경우 임상시험 데이터 관리를 위한 전산화 도입률 조차 낮은 실정이다. 본 연구는 전자적 임상시험 데이터 관리에 대한 중요성 인식 확산을 위하여 전자적 시스템의 효과에 대한 실증연구를 시도하였으며, 시간효율성 측정지표를 활용하여 다기관 임상시험 사례의 자료를 분석하였다. 연구결과로서 전자적 시스템으로의 전환이 임상시험 전체 프로세스에 제공할 수 있는 시간 측면에서의 효율성을 검증하였으며 전자적 임상시험 데이터 관리 시스템의 활용 효과를 분석하기 위한 국내 첫 실증연구의 시도라는 의미가 있다. 나아가 전략적 데이터 관리 수립 및 임상단계 별 비교연구 등 향후 다양한 비교 연구들의 초석이 될 것이다.

혈전증(血栓症) 및 고점도혈증(高粘度血症)에 관(關)한 보양환오탕(補陽還五湯)의 실험적(實驗的) 연구(硏究) (Study on the effect of Boyanghwanotang on Thrombosis and Elevated Blood Viscosity)

  • 송효정
    • 대한한방내과학회지
    • /
    • 제10권1호
    • /
    • pp.137-155
    • /
    • 1989
  • In order investigate the effect of Boyanghwanotang (BT) on thrombosis, Sprague-Dawley rats injected endotoxin into the caudal vein were oral administrated solid extract of BT-182. 4mg/200g (Sample A) and 364.8mg/200g (Sample B), and then observed Platelet, fibrinogen, prothrombin time and FDP. Another group injected hydrocortisone acetate into the muscular rump were adopted to observe the effect of BT on elevated blood Viscosity, administrated Sample A and Sample B, thereafter measured body weight, body temperature, whole blood viscosity, plasma viscosity, hematocrit, RBC, WBC, hemoglobin, glucose, albumin, total protein, triglyceride, cholesterol and prothrombin time. 1. Platelet was increased significantly in Sample B compared with the control group. 2. Fibrinogen of the trial groups compared with the control group was increased, and revealed a significance in Sample B. 3. Prothrombin time was decreased significantly in the trial groups compared with the control group. 4. FDP was decreased in the trial groups compared with the control group. 5. Body weight was increased significantly in Sample B after 7 days, body temperature revealed a significance in the trial groups after 5 days. 6. Whole blood viscosity and plasma viscosity of lower shear rates, both were highly decreased in the trial groupn than the control group. 7. The increase of WBC and decrease of hematocrit, RBC and hemoglobin was showed in the trial groups, and Sample B revealed a significance on the increase of WBC and decrease of RBC. 8. The increase of prothrombin time and decrease of glucose, albumin, total protein, triglyceride and cholesterol was showed in the trial group, and Sample B revealed a Significance on the increase of prothrombin time and decrease of albumin, total protein and triglyceride. 9. As compare with Sample A and Sample B, generally Sample B was highly Significant. According to the above results, it was considered that Boyanghwanotang may be the curative effects for thrombosis and elevated blood viscosity.

  • PDF

초공동 고속 캐비테이션 터널 구동펌프 개발 (Development of the Driving Pump for the Super-cavitation & High-speed Cavitation Tunnel)

  • 안종우;김건도;백부근;김경열
    • 대한조선학회논문집
    • /
    • 제55권2호
    • /
    • pp.153-160
    • /
    • 2018
  • In order to develop the driving pump for High-speed Cavitation Tunnel(HCT) which can experiment the super-cavitating submerged body, KRISO decided on the pump specification, designed the mixed-flow pump on the basis of the existing pump data and predicted the performance of the design pump using commercial CFD code (CFX-10). After the manufacture and installation of the driving pump, KRISO conducted the trial-test for HCT, analyzed the pump performance and compared trial-test results to those of design stage. The trial-test items for the HCT driving pump are measurements of output current/voltage at the inverter of the driving pump and the flow velocity in the HCT test section. The trial-test results showed the decrease in the flow rate of about 4.6% and the increase in pump head of about 8%, compared with those of the pump prediction. After the trial-test, the performance of the driving pump is predicted using CFX-10 with measured flowrates and pump rotational velocities. Though there is some difference between trial-test and prediction results due to inadequate motor data, it is thought that the tendency is reasonable. It is found that CFX-10 is useful to predict a mixed-flow pump.

Recruitment and enrollment in a randomized clinical trial of mandibular two-implant overdenture

  • Lee, Jeong-Yol;Kim, Min-Soo;Kim, Ha-Young;Shin, Sang-Wan
    • The Journal of Advanced Prosthodontics
    • /
    • 제5권2호
    • /
    • pp.204-208
    • /
    • 2013
  • PURPOSE. The purpose of this study was to evaluate the effectiveness of a promotion campaign for subject recruitment and selection, and reasons of withdrawal from a prospective clinical trial of mandibular two-implant supported overdenture. MATERIALS AND METHODS. The subjects of this study were participants in a randomized controlled clinical trial for investigating prognosis of implants and overdentures with attachments. Recruited subjects were classified by gender, age, and participation motives. Withdrawal rate of the participants before and after enrollment were evaluated. RESULTS. 177 patients were recruited and 51 patients were enrolled for the trial. Among them, 40 participants eventually took part in the trial. 116 subjects (65.5%) were recruited by advertisement and 61 (34.5%) were referred by patients of the hospital or local clinics. Regarding recruitment effectiveness, newspaper recruited the largest number of participants. With respect to referral patients, the proportion of our hospital patients was higher (37/61). Subjects in their 70s comprised the largest proportion (22/51). The male to female ratio was similar (25:26). Final withdrawal rate of all subjects were 74.0%. Among the reasons for withdrawal from enrollment (n=126) presence of remaining teeth and lack of motivation were the most common reasons. CONCLUSION. To facilitate recruitment of clinical trial subjects and improve enrollment rate, it is important to obtain a sufficient number of researchers, perform promotion activity with diverse strategies, cooperate with local dentists, increase the research funding, and alleviate subjects' fear against clinical trials by thorough consultation.

한국과 중국, 대만, 일본의 전통약 임상시험 현황에 대한 연구 (An Investigation about the Present States of Clinical Trial for Traditional Medicine in Korea, China, Taiwan and Japan)

  • 이경구;배순희;신현규
    • 한국한의학연구원논문집
    • /
    • 제12권1호
    • /
    • pp.13-22
    • /
    • 2006
  • Background and Aims: Herbal drugs and traditional medicines have lately attracted considerable attention by global pharmaceutical corporations because the conventional chemical drugs didn't work well for many chronic diseases or intractable diseases. The government of Korea is also supporting to develop the new drug which is high value added product, and the natural medicine including herbal medicine(or Traditional Korean Medicine) have a significant presence in this field. non-clinical pharmacology/toxicology study and clinical trial are the two major criteria which estimate efficacy and safety for registration of new drugs. All of the pharmaceutical companies producing herbal medicine and the academic and the academic world of Tradition Korean Medicine have the will to develop new herbal drugs, but there are obstacles that they have neither experience nor guideline about clinical trial. Therefore for developing new herbal drugs, it is necessary to research the present conditions and comprehensive systems about clinical trial in Northeast Asian countries China, Taiwan and Japan because they have the common background with Korea in traditional medicine fields. Methods : The present state of clinical trial for herbal medicine in Korea was investigated. And then, those in China, Taiwan, Japan was also investigated. Results and conclusions : There are significant differences among 4 Southeast Asian countries Korea, China, Taiwan and Japan each in present condition, purpose, involved comprehensive system including legislation, and actual operation of clinical trial for traditional medicine.

  • PDF

ISDN Field Trial 현황

  • 조평동
    • ETRI Journal
    • /
    • 제9권4호
    • /
    • pp.162-172
    • /
    • 1987
  • 세계 통신 선진국가에서 이루어지고 었는 ISDN의 동향과 그 field trial 현황에 대해 설명하였다.

  • PDF